Business Of Biotech cover image

Inhalable mRNA with Ethris' Carsten Rudolph, Ph.D.

Business Of Biotech

CHAPTER

Introduction

The host introduces the podcast show and discusses the current status of COVID-19 vaccination rates in the US. Dr. Karsten Rudoff, CEO at ETHRIS, is interviewed about his work on developing intranasally administered and inhaled vaccines and therapeutics for respiratory indications, including COVID-19.

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner